Stamford, CT -- (SBWIRE) -- 10/28/2013 -- Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletter and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Here are some trending Stocks in focus: Societe Generale SA (ADR) (OTCMKTS:SCGLY), Cliffs Natural Resources Inc (NYSE:CLF), CAN-FITE BIOPHARMA (OTCMKTS:CANFY), Kao Corporation (ADR) (OTCMKTS:KCRPY)
Societe Generale SA (ADR) (OTCMKTS:SCGLY) stock is at $11.30, down -0.70 percent from its previous close of $11.38. The stock opened the session at $11.32 and touched its highest price point at $11.32. SCGLY stock’s lowest price point for the session stood at $11.18.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive +39.85% during the previous three months trade. Societe Generale Group provides retail banking, specialized financial and insurance, private banking, investment management, and corporate and investment banking services worldwide. It offers domestic retail banking services through a network of 3,176 branches to individuals, professionals, associations, businesses.
Has SCGLY Found The Bottom and Ready To Move Up? Find Out Here
Cliffs Natural Resources Inc (NYSE:CLF) stock is at $24.99, up +5.98 percent from its previous close of $23.58. Its today’s volume is 18.96 million shares, in comparison to its average trading volume of 7.38 million shares. The stock opened the session at $24.57 and touched its highest price point at $25.63.
CLF’s lowest price point for the session stood at $23.81 and its 52 week price range stood at $15.41 - $40.40. Cliffs Natural Resources Inc., a mining and natural resources company, engages in the production of iron ore pellets, fines and lump ore, and metallurgical coal. It operates five iron ore mines located in Michigan and Minnesota; five metallurgical coal mines located in West Virginia and Alabama; and one thermal coal mine located in West Virginia.
For How Long CLF will fight for Profitability? Read This Trend Analysis report
CAN-FITE BIOPHARMA (OTCMKTS:CANFY) opened the session at $6.28 and remained in the $6.22 to $6.36 price range during the session. The stock is +1.45 percent higher, at $6.29. Volume closed the day at 117,122 shares, its average volume being 21,171 shares.
The company has a total market capitalization is $44.89 million. Its earnings per share was $1.10. Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases. The company principally develops CF101 that is in Phase III study for the treatment of psoriasis; and has completed Phase II study for the treatment of rheumatoid arthritis and glaucoma, as well as completed Phase III study for the treatment of dry eye and Phase I study for the treatment of uveitis.
Will CANFY Continue To Move Higher? Find Out Here
Kao Corporation (ADR) (OTCMKTS:KCRPY) traded in the range of $31.82 and $31.85 in its previous trading session. The stock recorded the volume of 25,619 shares, in comparison to its average daily trading volume of 21,138 shares.
Company’s year to date performance remained optimistic with the rise of +22.64%. The stock opened at $31.92 and its closing price for the day was $31.85, down -1.91. Kao Corporation, together with its subsidiaries, engages in the production, distribution, marketing, and sale of beauty care, human health care, and fabric and home care products; and chemicals worldwide.
Will KCRPY Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)